305 related articles for article (PubMed ID: 31826004)
1. MicroRNA profiling in canine multicentric lymphoma.
Craig KKL; Wood GA; Keller SM; Mutsaers AJ; Wood RD
PLoS One; 2019; 14(12):e0226357. PubMed ID: 31826004
[TBL] [Abstract][Full Text] [Related]
2. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas.
Garnica TK; Lesbon JCC; Ávila ACFCM; Rochetti AL; Matiz ORS; Ribeiro RCS; Zoppa A; Nishiya AT; Costa MT; de Nardi AB; Argyle DJ; Strefezzi RF; Silveira JC; Fukumasu H
Sci Rep; 2020 Nov; 10(1):20371. PubMed ID: 33230132
[TBL] [Abstract][Full Text] [Related]
4. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
Wang SL; Lee JJ; Liao AT
Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma.
Al-Nadaf S; Rebhun RB; Curran KM; Venable RO; Skorupski KA; Willcox JL; Burton JH
BMC Vet Res; 2018 Nov; 14(1):356. PubMed ID: 30458771
[TBL] [Abstract][Full Text] [Related]
6. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma.
Lucas SR; Maranhão RC; Guerra JL; Coelho BM; Barboza R; Pozzi DH
Vet Comp Oncol; 2015 Sep; 13(3):184-93. PubMed ID: 23615221
[TBL] [Abstract][Full Text] [Related]
7. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
Back AR; Schleis SE; Smrkovski OA; Lee J; Smith AN; Phillips JC
Vet Comp Oncol; 2015 Dec; 13(4):398-408. PubMed ID: 23910023
[TBL] [Abstract][Full Text] [Related]
8. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
Cornish N; Maybury B; Otton S
Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
[No Abstract] [Full Text] [Related]
9. Gene expression profiles associated with early relapse during first remission induction in canine multicentric high-grade B-cell lymphoma.
Toyoda H; Tani A; Goto-Koshino Y; Motegi T; Sakamoto M; Mochizuki T; Harada K; Kobayashi T; Setoguchi A; Shizuta Y; Mizuno T; Irie M; Nakamichi J; Tsujimoto H; Ohmi A; Fukuoka R; Nakamura Y; Tomiyasu H
J Vet Med Sci; 2024 Jan; 86(1):18-27. PubMed ID: 37952972
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of baseline absolute lymphocyte concentration and neutrophil/lymphocyte ratio in dogs with newly diagnosed multi-centric lymphoma.
Mutz M; Boudreaux B; Kearney M; Stroda K; Gaunt S; Shiomitsu K
Vet Comp Oncol; 2015 Dec; 13(4):337-47. PubMed ID: 23786518
[TBL] [Abstract][Full Text] [Related]
11. RNA disruption indicates CHOP therapy efficacy in canine lymphoma.
Parissenti AM; Pritzker LB; Guo B; Narendrula R; Wang SX; Lin LL; Pei J; Skowronski K; Bienzle D; Woods JP; Pritzker KPH; Coomber BL
BMC Vet Res; 2019 Dec; 15(1):453. PubMed ID: 31842875
[TBL] [Abstract][Full Text] [Related]
12. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy.
Curran KM; Schaffer PA; Frank CB; Lana SE; Hamil LE; Burton JH; Labadie J; Ehrhart EJ; Avery PR
Vet Comp Oncol; 2017 Dec; 15(4):1269-1279. PubMed ID: 27514648
[TBL] [Abstract][Full Text] [Related]
13. High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma.
Berglund M; Hedström G; Amini RM; Enblad G; Thunberg U
Oncol Rep; 2013 Feb; 29(2):720-4. PubMed ID: 23232598
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
[TBL] [Abstract][Full Text] [Related]
15. Whole genome sequencing analysis of high confidence variants of B-cell lymphoma in Canis familiaris.
Sparks A; Woods JP; Bienzle D; Wood GA; Coomber BL
PLoS One; 2020; 15(8):e0238183. PubMed ID: 32857815
[TBL] [Abstract][Full Text] [Related]
16. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?
Kim WS; Song SY; Ahn YC; Ko YH; Baek CH; Kim DY; Yoon SS; Lee HG; Kang WK; Lee HJ; Park CH; Park K
Ann Oncol; 2001 Mar; 12(3):349-52. PubMed ID: 11332147
[TBL] [Abstract][Full Text] [Related]
17. Response-based modification of CHOP chemotherapy for canine B-cell lymphoma.
Benjamin SE; Sorenmo KU; Krick EL; Salah P; Walsh KA; Weinstein NM; Keuler NS; Avery AC; Atherton MJ; Lenz JA
Vet Comp Oncol; 2021 Sep; 19(3):541-550. PubMed ID: 33729654
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.
Burton JH; Garrett-Mayer E; Thamm DH
Vet Comp Oncol; 2013 Dec; 11(4):306-15. PubMed ID: 22548975
[TBL] [Abstract][Full Text] [Related]
19. Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B- and T-Cell lymphomas.
Uhl E; Krimer P; Schliekelman P; Tompkins SM; Suter S
Genes Chromosomes Cancer; 2011 Nov; 50(11):950-67. PubMed ID: 21910161
[TBL] [Abstract][Full Text] [Related]
20. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
Meichner K; Fogle JE; English L; Suter SE
J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
